Pilar Sánchez Gómez

A team of Spanish researchers has investigated the early stages of metastatic cells taking hold in target organs and has discovered that there is a transitional stage during which these ‘metastatic seeds’ are particularly vulnerable. They have also demonstrated in mice and in human samples that these micrometastases can be eliminated using three drugs, two of which are already approved for other indications. The study is published in the journal Cancer Cell.

A drug in gel form cured 100 percent of mice with a very aggressive brain tumor. The authors hope that this is a first step towards helping human patients with glioblastoma, one of the most dangerous brain tumors in humans. The article is published today in PNAS.

Between 10-15% of childhood brain tumours are diffuse midline gliomas, a type of tumour that occurs within the brainstem, making it almost impossible to remove surgically. Research published in Science Translational Medicine has used a type of molecule (antisense-ASO oligonucleotides) in mouse models of this tumour to slow tumour growth and prolong survival. The authors hope that the research will reach clinical trials and, in that case, the potential new treatment would be combined with others such as radiotherapy or immunotherapy with CAR-T cells.